The ABCD-GENE score, which incorporates age, BMI, chronic kidney disease, diabetes mellitus and CYP2C19 loss-of-function alleles, has been demonstrated among Chinese minor stroke/TIA patients to identify subjects at increased risk of stroke recurrence following clopidogrel-aspirin therapy [39]. This evidence concerns the gene CYP2C19 and chronic kidney disease.